Serum prolactin concentrations determine whether they improve or impair β‐cell function and insulin sensitivity in diabetic rats
- 10 May 2011
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 27 (6) , 564-574
Abstract
Background: Prolactin improves glucose homeostasis by increasing β‐cell mass under certain conditions such as pregnancy, whereas hyperprolactinaemia due to a pituitary gland adenoma tumour exacerbates insulin resistance. However, previous studies have not evaluated how prolactin modulates β‐cell function and insulin sensitivity at different dosages. Here, we determined that chronic intraperitoneal injections of different dosages of prolactin have opposite effects on insulin resistance and β‐cell function and mass in 90% pancreatectomized diabetic male rats, and the mechanisms were explored.Methods: Diabetic rats were divided into three groups according to the dose of intraperitoneally injected prolactin for 4 weeks: (1) low dose of prolactin (25 µg/kg bw/12 h), (2) high dose of prolactin (250 µg/kg bw/12 h), and (3) vehicle. As a non‐diabetic control group, sham‐operated rats were injected with vehicle.Results: Chronic high‐ and low‐dose prolactin injections elevated serum prolactin levels by 2.5‐ and 11.8‐fold, respectively. Both dosages promoted β‐cell mass by increasing β‐cell proliferation and neogenesis through the potentiation of phosphorylation of signal transducer and activator of transcription 5 and decreased menin expression in diabetic rats. However, only the low‐dose prolactin injection potentiated glucose‐stimulated insulin secretion though glucokinase and glucose transporter 2 induction in the diabetic rats. In addition, low‐dose prolactin decreased hepatic glucose output in hyperinsulinaemic states, indicating an improvement in hepatic insulin resistance. However, the high‐dose prolactin injection exacerbated whole‐body and hepatic insulin resistance in diabetic rats.Conclusions: In contrast to the normal adaptive increases in glucose‐stimulated insulin secretion through expanded β‐cell mass and insulin sensitivity realized with moderately increased prolactin levels, high levels of prolactin exacerbate insulin resistance and impair the insulin‐secretory capacity in diabetic mice. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 47 references indexed in Scilit:
- Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)Diabetes Care, 2011
- Cortisol Is Negatively Associated with Insulin Sensitivity in Overweight Latino YouthThe Journal of Clinical Endocrinology & Metabolism, 2010
- Serotonin regulates pancreatic beta cell mass during pregnancyNature Medicine, 2010
- Minireview: Meeting the Demand for Insulin: Molecular Mechanisms of Adaptive Postnatal ß-Cell Mass ExpansionMolecular Endocrinology, 2009
- Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and β-cell mass to age-related insulin resistance in ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Adipocyte prolactin: regulation of release and putative functionsDiabetes, Obesity and Metabolism, 2006
- Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissueBiochemical and Biophysical Research Communications, 2005
- Prevention of fat-induced insulin resistance by salicylateJournal of Clinical Investigation, 2001
- Chronic effect of hyperprolactinemia on blood glucose and lipid levels in miceLife Sciences, 1996
- Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37).Journal of Clinical Investigation, 1996